Literature DB >> 1970106

Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies.

B J Weiblen1, F K Lee, E R Cooper, S H Landesman, K McIntosh, J A Harris, S Nesheim, H Mendez, S I Pelton, A J Nahmias.   

Abstract

With the aim of achieving earlier diagnosis of human, immunodeficiency virus (HIV) infection in infants, IgA and IgM HIV antibodies in serum samples from babies born to seropositive mothers were assayed by immunoblot and enzyme-linked immunosorbent assay after removal of IgG with recombinant protein G. 64 samples were from 38 HIV-infected babies with Centers for Disease Control classifications of P1 or P2. Among these infected children IgA HIV antibodies were present in all 23 samples from those older than 12 months, in 12 of 18 samples from babies aged 6-12 months, in 5 of 10 samples from babies aged 3-5 months, and in 2 of 13 from babies under 3 months old. The 6 IgA-negative samples from infants over 6 months were all from infants with severe AIDS and/or hypogammaglobulinaemia. IgA HIV antibodies were present in twice as many samples as IgM HIV antibodies (66% vs 33%). No IgM or IgA HIV antibodies were detected in infants who subsequently seroreverted or in infants born to seronegative mothers. The correlation of the serological results with clinical information on each child suggests that detection of IgA HIV antibodies is an effective method for early diagnosis of HIV-infected infants without signs of infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970106     DOI: 10.1016/0140-6736(90)91061-e

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

1.  HIV antibodies in babies.

Authors:  J A Connell; J V Parry; P P Mortimer; S M Burns; A Klokke; A De Rossi; C Giaquinto
Journal:  BMJ       Date:  1992-08-08

2.  Postnatal human immunodeficiency virus antibody testing. The effects of current policy on infant care and maternal informed consent.

Authors:  P Lester; J C Partridge; M Cooke
Journal:  West J Med       Date:  1992-04

3.  Severe illness in African children with diarrhoea: implications for case management strategies.

Authors:  L A Lee; R Dogore; S C Redd; E Dogore; B Metchock; J Diabate; O W van Assendelft; K DeCock; E Patrick; J Herrington
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

4.  Diagnosis of human immunodeficiency virus infection using an immunoglobulin E-based assay.

Authors:  M Fletcher; M J Miguez-Burbano; G Shor-Posner; V Lopez; H Lai; M K Baum
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

Review 5.  Pediatric human immunodeficiency virus infection.

Authors:  J B Domachowske
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

6.  Prognostic value of serum immunoglobulin A antibodies to pol gene products during HIV-1 infection.

Authors:  A Quesnel; B Pozzetto; P Moja; F Grattard; F R Lucht; J L Touraine; O G Gaudin; C Genin
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Early detection of IgA specific antibodies in HIV-1 infected children by peptide-ELISA and peptide time-resolved fluoro-immunoassay.

Authors:  V Lombardi; M Caniglia; G Scarlatti; M Jansson; A Plebani; P D'Argenio; S Scaccia; H Wigzell; P Rossi
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

9.  Simian immunodeficiency virus infection in neonatal macaques.

Authors:  Ronald S Veazey; Jeffrey D Lifson; Ivona Pandrea; Jeannette Purcell; Michael Piatak; Andrew A Lackner
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody.

Authors:  J L Gallarda; D R Henrard; D Liu; S Harrington; S L Stramer; J E Valinsky; P Wu
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.